GRP78 (78-kDa glucose-regulated protein) is a potentially useful biomarker for predicting response and survival outcome in patients with multiple myeloma, and is a potentially useful target in the treatment of multiple myeloma.

Hang Quach, Daniel North, S.Y Tan, Susanna Freddi, L Straszkowski, Harshal Hanumant Nandurkar

Research output: Contribution to conferenceAbstractpeer-review

Original languageEnglish
Publication statusPublished - 2015

Cite this